DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lantus (Insulin Glargine) - Current Clinical Trials

 
 



Lantus Related Clinical Trials

Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) [Completed]

Lantus in Prediabetes [Completed]

Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus [Completed]

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) [Completed]

Euglycemic Clamp Dose-response Study Comparing Insulin Glargine U300 With Lantus® U100 [Recruiting]

AT.LANTUS: A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus [Completed]

Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes [Active, not recruiting]

Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) [Completed]

Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analog Glargine in Type 1 Diabetic Patients [Not yet recruiting]

Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients [Recruiting]

Insulin Glulisine Administered Pre-Meal Versus Post-Meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin [Completed]

A Clinical Trial Comparing the Efficacy and Safety of Exubera and Lantus [Active, not recruiting]

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. [Recruiting]

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes [Not yet recruiting]

Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency [Recruiting]

Comparison of a New Formulation of Insulin Glargine With Lantus in Japanese Patients With Type 1 Diabetes Mellitus [Recruiting]

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin [Recruiting]

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus [Recruiting]

Comparison of a New Formulation of Insulin Glargine With Lantus Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus [Recruiting]

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic Therapy [Recruiting]

Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus [Recruiting]

Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes [Recruiting]

Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus [Recruiting]

Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use [Recruiting]

A Study to Compare LY2963016 and US-approved Lantus® After Single Dose Administration to Healthy Participants [Recruiting]

Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis [Not yet recruiting]

Lispro Mix 25 vs. Glargine in Type 2 Diabetics [Completed]

The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes [Not yet recruiting]

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes [Recruiting]

Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes [Completed]

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) [Active, not recruiting]

Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment [Completed]

A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes [Completed]

JanUmet Before Insulin Lantus In Eastern Population Evaluation Program (JUBILEE) In Type 2 Diabetic Patients [Not yet recruiting]

DPP4 Inhibitor in the Hospital [Not yet recruiting]

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment [Recruiting]

The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing [Completed]

A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes [Not yet recruiting]

A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Subjects [Recruiting]

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine [Recruiting]

BASAAL PLUS - Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting [Recruiting]

LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus [Completed]

A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus [Completed]

Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agent Failure [Recruiting]

Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) Failure [Not yet recruiting]

Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents [Recruiting]

Comparison of Lantus and NPH Insulin in the Dawn Phenomenon [Recruiting]

Simplified Insulin Protocol Using Lantus in Elderly [Recruiting]

Comparing Long-acting Insulins During Exercise in Type 1 Diabetes [Recruiting]

20 Week Bridging Study in Type II DM [Completed]

Pharmacodynamic and Pharmacokinetic Variability of a Basal Insulin (0000-168) [Recruiting]

Satisfaction of Treatment Among Elderly Patients With Insulin Therapy [Recruiting]

Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes [Completed]

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents [Completed]

Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine [Active, not recruiting]

Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes [Completed]

Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 Diabetes [Recruiting]

Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) [Completed]

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR) [Recruiting]

24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin Glargine [Recruiting]

Insulin Glargine at Bedtime or in AM Versus NPH [Recruiting]

An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice [Completed]

Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2) [Recruiting]

Basal Insulins - Pharmacodynamics [Completed]

Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1 [Recruiting]

Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks [Recruiting]

Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive Patients: LANTU_C_02761 (NCT00751114) Extension Trial [Recruiting]

Characteristics of Glargine in Type 2 Diabetics [Recruiting]

Insulin Glargine "All to Target" Trial [Recruiting]

Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control [Active, not recruiting]

baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus [Recruiting]

Insulin Glargine in Type 2 Diabetes

Glycemic Optimization Treatment Study [Completed]

Insulin Glargine in Type 1 Diabetes Mellitus [Completed]

Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glargine [Recruiting]

Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin [Completed]

Apidra Children& Adolescents Study [Not yet recruiting]

Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de DiabĂ©ticos Tipo 2) [Recruiting]

Insulin Glargine Versus Twice-Daily NPH [Recruiting]

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine [Not yet recruiting]

Comparative Trial Between Insulin Glargine Plus Apidra Versus Sliding Scale Regular Insulin In Hospitalized Patients With Type 2 Diabetes [Completed]

Lantus in the Treatment of Type 1 Diabetes Children

Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes [Completed]

Exubera vs Lispro in a Lantus-Based Regimen for Improved Glycemic Control in Type 2 Diabetes [Active, not recruiting]

Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus [Recruiting]

SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1

Insulin Glargine During and After the Period of Fasting in Ramadan [Completed]

Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as Add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin

32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus [Completed]

L2T3 (Lantus Versus Levemir Treat-To-Target) [Active, not recruiting]

Insulin Glargine in Type 2 Diabetes Mellitus [Completed]

6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes [Recruiting]

24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine [Completed]

One Year Glargine Treatment in CFRD Children and Adolescents [Completed]

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) [Recruiting]

EFFECT of Insulin Glargine and Apidra in Patients With Acute ST Elevation MI [Recruiting]

DOMME Dose Optimization Multicentric Mexican Evaluation [Recruiting]

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes [Completed]

Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study [Recruiting]

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy [Completed]

Endothelial Effects of Basal Insulin: Detemir Versus Glargine [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014